{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:12:09Z","timestamp":1777392729060,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,12,2]],"date-time":"2014-12-02T00:00:00Z","timestamp":1417478400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,12,2]],"date-time":"2014-12-02T00:00:00Z","timestamp":1417478400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s12013-014-0402-x","type":"journal-article","created":{"date-parts":[[2014,12,2]],"date-time":"2014-12-02T13:49:58Z","timestamp":1417528198000},"page":"49-56","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Lower Serum Bilirubin and Uric Acid Concentrations in Patients with Parkinson\u2019s Disease in China"],"prefix":"10.1007","volume":"72","author":[{"given":"Xiao-ling","family":"Qin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing-shan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng-wei","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhao-ting","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,12,2]]},"reference":[{"issue":"suppl 3","key":"402_CR1","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1002\/ana.10483","volume":"53","author":"P Jenner","year":"2003","unstructured":"Jenner, P. (2003). Oxidative stress in Parkinson\u2019s disease [J]. Annals of Neurology, 53(suppl 3), S26\u2013S36.","journal-title":"Annals of Neurology"},{"issue":"11","key":"402_CR2","doi-asserted-by":"publisher","first-page":"6858","DOI":"10.1073\/pnas.78.11.6858","volume":"78","author":"BN Ames","year":"1981","unstructured":"Ames, B. N., Cathcart, R., Schwiers, E., et al. (1981). Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: A hypothesis. Proceedings of the National Academy of Sciences of the United States of America, 78(11), 6858\u20136862.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"4792","key":"402_CR3","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1126\/science.3029864","volume":"235","author":"R Stocker","year":"1987","unstructured":"Stocker, R., Yamamoto, Y., McDonagh, A. F., et al. (1987). Bilirubin is an antioxidant of possible physiological importance [J]. Science, 235(4792), 1043\u20131046.","journal-title":"Science"},{"issue":"13","key":"402_CR4","doi-asserted-by":"publisher","first-page":"5171","DOI":"10.1073\/pnas.0813132106","volume":"106","author":"TW Sedlak","year":"2009","unstructured":"Sedlak, T. W., Saleh, M., Higginson, D. S., et al. (2009). Bilirubin and glutathione have complementary antioxidant and cytoprotective roles [J]. Proceedings of the National Academy of Sciences of the United States of America, 106(13), 5171\u20135176.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"25","key":"402_CR5","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/0024-3205(94)90140-6","volume":"54","author":"TW Wu","year":"1994","unstructured":"Wu, T. W., Fung, K. P., & Yang, C. C. (1994). Unconjugated bilirubin inhibits the oxidation of human low density lipoprotein better than Trolox. Life Sciences, 54(25), 477\u2013481.","journal-title":"Life Sciences"},{"issue":"24","key":"402_CR6","doi-asserted-by":"publisher","first-page":"9748","DOI":"10.1073\/pnas.85.24.9748","volume":"85","author":"B Frei","year":"1988","unstructured":"Frei, B., Stocker, R., & Ames, B. N. (1988). Antioxidant defenses and lipid peroxidation in human blood plasma. Proceedings of the National Academy of Sciences of the United States of America, 85(24), 9748\u20139752.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"3","key":"402_CR7","doi-asserted-by":"publisher","first-page":"253","DOI":"10.2174\/1389557033488213","volume":"3","author":"RP McGeary","year":"2003","unstructured":"McGeary, R. P., Szyczew, A. J., & Toth, I. (2003). Biological properties and therapeutic potential of bilirubin[J]. Mini-Reviews in Medicinal Chemistry, 3(3), 253\u2013256.","journal-title":"Mini-Reviews in Medicinal Chemistry"},{"issue":"5","key":"402_CR8","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1111\/jnc.12038","volume":"123","author":"L Gong","year":"2012","unstructured":"Gong, L., Zhang, Q. L., Zhang, N., et al. (2012). Neuroprotection by urate on 6-OHDA-lesioned rat model of Parkinson\u2019s disease: Linking to Akt\/GSK3\u03b2signaling pathway [J]. Journal of Neurochemistry, 123(5), 876\u2013885.","journal-title":"Journal of Neurochemistry"},{"issue":"12","key":"402_CR9","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1093\/aje\/kwn273","volume":"168","author":"G Logroscino","year":"2008","unstructured":"Logroscino, G., Gao, X., Chen, H., et al. (2008). Dietary Iron intake and risk of Parkinson\u2019s disease [J]. American Journal of Epidemiology, 168(12), 1381\u20131388.","journal-title":"American Journal of Epidemiology"},{"issue":"5","key":"402_CR10","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/aje\/kwm127","volume":"166","author":"MG Weisskopf","year":"2007","unstructured":"Weisskopf, M. G., O\u2019Reily, E., Chen, H., et al. (2007). Plasma urate and risk of Parkinson\u2019S disease [J]. American Journal of Epidemiology, 166(5), 561\u2013567.","journal-title":"American Journal of Epidemiology"},{"key":"402_CR11","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/0014-5793(94)00666-0","volume":"349","author":"V Gopinathan","year":"1994","unstructured":"Gopinathan, V., Miller, N. J., Milner, A. D., & Rice-Evans, C. A. (1994). Bilirubin and ascorbate antioxidant activity in neonatal plasma. FEBS Letters, 349, 197\u2013200.","journal-title":"FEBS Letters"},{"issue":"5","key":"402_CR12","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1073\/pnas.96.5.2445","volume":"96","author":"S Dore","year":"1999","unstructured":"Dore, S., Takahashi, M., Ferris, C. D., et al. (1999). Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury [J]. Proceedings of the National Academy of Sciences of the United States of America, 96(5), 2445\u20132450.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"402_CR13","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1749-6632.1999.tb07991.x","volume":"890","author":"S Dore","year":"1999","unstructured":"Dore, S., & Snyde, S. H. (1999). Neuroprotective action of bilirubin against oxidative stress in primary hippocampal cultures [J]. Annals of the New York Academy of Sciences, 890, 167\u2013172.","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"3","key":"402_CR14","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/S1357-2725(01)00130-3","volume":"34","author":"ML Tomaro","year":"2002","unstructured":"Tomaro, M. L., & Batlle, A. M. (2002). Bilirubin: Its role in cytoprotection against oxidative stress[J]. International Journal of Biochemistry & Cell Biology, 34(3), 216\u2013220.","journal-title":"International Journal of Biochemistry & Cell Biology"},{"issue":"12","key":"402_CR15","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1136\/gut.52.12.1774","volume":"52","author":"A Granato","year":"2003","unstructured":"Granato, A., Gores, G., Vilei, M. T., et al. (2003). Bilirubin inhibits bile acid induced apoptosis in rat hepatocytes[J]. Gut, 52(12), 1774\u20131778.","journal-title":"Gut"},{"key":"402_CR16","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/BF03401984","volume":"5","author":"S Dore","year":"1999","unstructured":"Dore, S., Sampei, K., Goto, S., et al. (1999). Heme oxygenase-2 is neuroprotective in cerebral ischemia. Molecular Medicine, 5, 656\u2013663.","journal-title":"Molecular Medicine"},{"key":"402_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0006-8993(99)01726-6","volume":"850","author":"N Panahian","year":"1999","unstructured":"Panahian, N., Huang, T., & Maines, M. D. (1999). Enhanced neuronal expression of the oxidoreductase-biliverdin reductase-after permanent focal cerebral ischemia. Brain Research, 850, 1\u201313.","journal-title":"Brain Research"},{"issue":"11","key":"402_CR18","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1002\/art.24193","volume":"59","author":"M De Vera","year":"2008","unstructured":"De Vera, M., Rahman, M. M., RamKin, J., et al. (2008). Gout and the risk of Parkinson\u2019s Disease: A cohort study[J]. Arthritis and Rheumatism, 59(11), 1549\u20131554.","journal-title":"Arthritis and Rheumatism"},{"issue":"8","key":"402_CR19","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/mds.21502","volume":"22","author":"T Annanmaki","year":"2007","unstructured":"Annanmaki, T., Muuronen, A., & Murros, K. (2007). Low plasma uric acid level in Parkinson\u2019s disease [J]. Movement Disorders, 22(8), 1133\u20131137.","journal-title":"Movement Disorders"},{"issue":"7","key":"402_CR20","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1093\/aje\/kwm385","volume":"167","author":"X Gao","year":"2008","unstructured":"Gao, X., Chen, H., Choi, H. K., et al. (2008). Diet, urate, and Parkinson\u2019s disease risk in men. American Journal of Epidemiology, 167(7), 831\u2013838.","journal-title":"American Journal of Epidemiology"},{"issue":"5","key":"402_CR21","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/ana.20663","volume":"58","author":"LM De Lau","year":"2005","unstructured":"De Lau, L. M., Koudstaal, P. J., Hofman, A., et al. (2005). Serum uric acid levels and the risk of Parkinson\u2019s disease. Annals of Neurology, 58(5), 797\u2013800.","journal-title":"Annals of Neurology"},{"issue":"5","key":"402_CR22","doi-asserted-by":"publisher","first-page":"701","DOI":"10.2217\/bmm.10.94","volume":"4","author":"S Cipriani","year":"2010","unstructured":"Cipriani, S., Chen, X., & Schwarzschild, M. A. (2010). Urate: A novel biomarker of Parkinson\u2019s disease risk, diagnosis and prognosis[J]. Biomarkers in Medicine, 4(5), 701\u2013712.","journal-title":"Biomarkers in Medicine"},{"issue":"5","key":"402_CR23","doi-asserted-by":"publisher","first-page":"e37331","DOI":"10.1371\/journal.pone.0037331","volume":"7","author":"S Cipriani","year":"2012","unstructured":"Cipriani, S., Desjardins, C. A., Burdett, T. C., et al. (2012). Urate and its transgenic depletion modulate neuronal vulnerability in a cellular model of Parkinson\u2019s disease [J]. PLoS One, 7(5), e37331.","journal-title":"PLoS One"},{"issue":"4","key":"402_CR24","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s12017-007-8010-1","volume":"9","author":"F Haberman","year":"2007","unstructured":"Haberman, F., Tang, S. C., Arumugam, T. V., et al. (2007). Soluble neuroprotective antioxidant uric acid analogs ameliorate ischemic brain injury in mice [J]. Neuromolecular Medicine, 9(4), 315\u2013323.","journal-title":"Neuromolecular Medicine"},{"issue":"6","key":"402_CR25","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1001\/archneur.2008.65.6.nct70003","volume":"65","author":"MA Schwarzschild","year":"2008","unstructured":"Schwarzschild, M. A., Schwid, S. R., Marek, K., et al. (2008). Serum urate as a predictor of clinical and radiographic progression in Parkinson\u2019s disease J]. Archives of Neurology, 65(6), 716\u2013723.","journal-title":"Archives of Neurology"},{"key":"402_CR26","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1002\/mds.22139","volume":"23","author":"I Schlesinger","year":"2008","unstructured":"Schlesinger, I., & Schlesinger, N. (2008). Uric acid in Parkinson\u2019s disease. Movement Disorders, 23, 1653\u20131657.","journal-title":"Movement Disorders"},{"key":"402_CR27","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0072-9752(07)83024-7","volume":"83","author":"P Jenner","year":"2007","unstructured":"Jenner, P. (2007). Oxidative stress and Parkinson\u2019s disease. Handbook of Clinical Neurology, 83, 507\u2013520.","journal-title":"Handbook of Clinical Neurology"},{"key":"402_CR28","unstructured":"Lotharius, J., Brundin, P. (2002). Pathogenesis of Parkinson\u2019s disease: Dopamine, vesicles and alpha-synuclein. Nature Reviews Neuroscience, 3(12):932\u201342."},{"issue":"1","key":"402_CR29","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.molbrainres.2004.11.007","volume":"134","author":"CM Testa","year":"2005","unstructured":"Testa, C. M., Sherer, T. B., & Greenamyre, J. T. (2005). Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures[J]. Brain Research. Molecular Brain Research, 134(1), 109\u2013118.","journal-title":"Brain Research. Molecular Brain Research"},{"key":"402_CR30","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1073\/pnas.61.2.748","volume":"61","author":"R Tenhunen","year":"1968","unstructured":"Tenhunen, R., Marver, H. S., & Schmid, R. (1968). The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proceedings of the National Academy of Sciences of the United States of America, 61, 748\u2013755.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"402_CR31","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1126\/science.126.3272.507-a","volume":"126","author":"D Schachter","year":"1957","unstructured":"Schachter, D. (1957). Nature of the glucuronide in direct-reacting bilirubin. Science, 126, 507\u2013508.","journal-title":"Science"},{"key":"402_CR32","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0304-4165(93)90013-X","volume":"1158","author":"T Nakagami","year":"1993","unstructured":"Nakagami, T., Toyomura, K., Kinoshita, T., et al. (1993). A beneficial role of bile pigments as an endougenous tissue protector: Anti-complement effects of biliverdin and conjugated bilirubin. Biophysica Acta, 1158, 189\u2013193.","journal-title":"Biophysica Acta"},{"issue":"3","key":"402_CR33","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S0021-9150(00)00420-2","volume":"154","author":"SC Hunt","year":"2001","unstructured":"Hunt, S. C., Kronenberg, F., Eckfeldt, J. H., et al. (2001). Association of plasma bilirubin with coronary heart disease and segregation of bilirubin as a major gene trait: The NHLBI family heart study [J]. Atherosclerosis, 154(3), 747\u2013754.","journal-title":"Atherosclerosis"},{"issue":"10","key":"402_CR34","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1016\/S0002-9149(01)01494-1","volume":"87","author":"L Djousse","year":"2001","unstructured":"Djousse, L., Levy, D., Cupples, L. A., et al. (2001). Total serum bilirubin and risk of cardiovascular disease in the Framingham offspring study[J]. American Journal of Cardiology, 87(10), 1196\u20131200.","journal-title":"American Journal of Cardiology"},{"key":"402_CR35","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0065-3101(24)00052-5","volume":"44","author":"GR Gourley","year":"1997","unstructured":"Gourley, G. R. (1997). Bilirubin metabolism and kernicterus [J]. Advances in Pediatrics, 44, 173\u2013229.","journal-title":"Advances in Pediatrics"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-014-0402-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12013-014-0402-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-014-0402-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-014-0402-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T14:21:56Z","timestamp":1717597316000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12013-014-0402-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,2]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["402"],"URL":"https:\/\/doi.org\/10.1007\/s12013-014-0402-x","relation":{},"ISSN":["1085-9195","1559-0283"],"issn-type":[{"value":"1085-9195","type":"print"},{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,2]]},"assertion":[{"value":"2 December 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}